These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 33085598

  • 1. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
    Regalado-Artamendi I, Pérez-Corral AM, García-Morín M, Cela E, Beléndez C, Bardón-Cancho EJ, Pérez-Rus G, Pérez-Sánchez I, Pascual C, Monsalvo S, Falero C, Díez-Martín JL, Anguita J.
    Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
    [Abstract] [Full Text] [Related]

  • 2. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U, Borhany M, Ansari S, Parveen S, Boota S, Shamim I, Zahid D, Shamsi T.
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Utilising red cell antigen genotyping and serological phenotyping in sickle cell disease patients to risk-stratify patients for alloimmunisation risk.
    Shih AW, Yan MTS, Elahie AL, Barty RL, Liu Y, Berardi P, Azzam M, Siddiqui R, Parvizian MK, Mcdougall T, Heddle NM, Al-Habsi KS, Goldman M, Cote J, Athale U, Verhovsek MM.
    Transfus Med; 2020 Aug; 30(4):263-274. PubMed ID: 32432400
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of red blood cell alloantibodies in pregnant women with sickle cell disease in Bamako.
    Fomba M, Toure B, N'dour CT, Bagayoko A, Baby M.
    Transfus Med; 2024 Oct; 34(5):421-427. PubMed ID: 39104031
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Red Cell Alloimmunisation Among Sickle Cell Disease and Thalassemia Patients Following Rh- and K-Matched Red Cell Transfusion in Southwestern Saudi Arabia: A Multicenter Study.
    Meshi AA, Abu-Tawil H, Hamzi AA, Madkhali BA, Maghfori AB, Alnami II, Hamali HA, Madkhali MM.
    Int J Gen Med; 2024 Oct; 17():2855-2864. PubMed ID: 38947563
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence and risk factors for red blood cell alloimmunisation among sickle cell patients in Mwanza City, Tanzania.
    Tebuka E, Charles M, Bhuko JO.
    Afr J Lab Med; 2020 Oct; 9(1):823. PubMed ID: 33102164
    [Abstract] [Full Text] [Related]

  • 15. The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England.
    Trompeter S, Estcourt L, Mora A, Wong E, Collett D, Bolton-Maggs P, Poles D, Deary A, Watt A.
    Transfus Med; 2020 Dec; 30(6):456-466. PubMed ID: 33103306
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Eleven years of alloimmunization in 6496 patients with sickle cell disease in France who received transfusion.
    Floch A, Viret S, Malard L, Pakdaman S, Jouard A, Habibi A, Galacteros F, François A, Pirenne F.
    Blood Adv; 2023 Dec 26; 7(24):7608-7620. PubMed ID: 37699002
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.